Hepatitis B Virus and Liver Disease

Editor Jia-Horng Kao is a Professor at the Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. Professor Ding-Shinn Chen is a Professor at the Genomics Research Center, and the Academician of Academic Sinica, Taipei, Taiwan.

Life cycle and molecular virology.- Unmet needs in basic research: in vitro and in vivo models.- Immunopathogenesis.- Epidemiology and natural history.- Hepatitis B vaccination.- Viral factors and disease progression.- Host genetic factors and disease progression.- Molecular carcinogenesis of HCC.- Interferon therapy and long-term outcomes.- Nucleotide therapy and long-term outcomes.- Combination therapy.- Treatment of patients with HCV, HDV or HIV co-infection.- Management of children and pregnant women.- Management of patients with immunosuppressive therapy.- Towards an HBV cure: discovery of novel agents.- Others: occult HBV infection.

“The purpose is to present updated information regarding the pathogenesis, epidemiology, and prevention of hepatitis B, with a strong emphasis on basic and translational medicine. The audience includes students, healthcare providers, and researchers interested in hepatitis B or who wish to stay up to date in this area. The book would be of the greatest benefit to research‐oriented readers and/or those working in geographic areas highly endemic in hepatitis B.” (Cezarina Mindru, Doody's Book Reviews, April, 2018)